Liraglutide biosimilar(Glenmark Pharmaceuticals)
N/A
Report date: 2026/05/12 20:00:17
Base Information
Drug NameLiraglutide biosimilar(Glenmark Pharmaceuticals)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2024/01/03
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesGlenmark Pharmaceuticals Ltd
China Registration ClassN/A
Develop Information
Active CompaniesGlenmark Pharmaceuticals Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A